Disc Medicine Inc (IRON)
41.62
-4.85
(-10.44%)
USD |
NASDAQ |
Jul 02, 16:00
43.69
+2.07
(+4.97%)
After-Hours: 20:00
Disc Medicine Free Cash Flow: -71.72M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -71.72M |
| December 31, 2023 | -73.55M |
| September 30, 2023 | -65.43M |
| June 30, 2023 | -67.62M |
| March 31, 2023 | -64.10M |
| December 31, 2022 | -42.40M |
| September 30, 2022 | -13.24M |
| Date | Value |
|---|---|
| June 30, 2022 | -19.68M |
| March 31, 2022 | -26.40M |
| December 31, 2021 | -27.60M |
| September 30, 2021 | -55.95M |
| June 30, 2021 | -46.75M |
| March 31, 2021 | -37.83M |
| December 31, 2020 | -32.71M |
Free Cash Flow Range, Past 5 Years
-73.55M
Minimum
Dec 2023
-13.24M
Maximum
Sep 2022
-46.07M
Average
-44.58M
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals Inc | 63.71M |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Marinus Pharmaceuticals Inc | -113.98M |
| Rocket Pharmaceuticals Inc | -209.70M |
| Regenxbio Inc | -198.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -33.60M |
| Cash from Investing (Quarterly) | -0.067M |
| Cash from Financing (Quarterly) | 15.90M |
| Free Cash Flow Per Share (Quarterly) | -1.357 |
| Free Cash Flow Yield | -7.25% |